Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2001
11/22/2001CA2408974A1 Cancer treatments by using a combination of an antibody against her2 and interleukin -2
11/22/2001CA2408961A1 Use of ajulemic acid and related cannabinoids for the treatment of cancer
11/22/2001CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001CA2408842A1 Method for treating retinal degeneration with purinergic receptor agonists
11/22/2001CA2408827A1 Novel human lipocalin homologs and polynucleotides encoding the same
11/22/2001CA2408745A1 Anti-angiogenic polypeptides
11/22/2001CA2408729A1 Delivery systems for treatment of vascular disease
11/22/2001CA2408719A1 Antiproliferative drug and delivery device
11/22/2001CA2408701A1 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001CA2408667A1 Phosphate transport inhibitors
11/22/2001CA2408608A1 Antiinflammatory drug and delivery device
11/22/2001CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001CA2408134A1 G-protein coupled receptors
11/22/2001CA2407469A1 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001CA2407222A1 New thiochromane derivatives and their use as thrombin inhibitors
11/22/2001CA2407099A1 Aralkyl ester soft drugs
11/22/2001CA2407088A1 Beta-secretase inhibitors
11/22/2001CA2405507A1 Use of pyrazole derivatives for treating infertility
11/22/2001CA2404704A1 Treatment of fibromyalgia and chronic fatigue syndrome
11/21/2001EP1156332A2 Assay methods for cyclin dependent kinases
11/21/2001EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction
11/21/2001EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001EP1156057A1 Malto-oligosaccharide derivatives and uses thereof
11/21/2001EP1156054A1 Drugs containing phosphoric acid derivatives as the active ingredient
11/21/2001EP1156050A2 Substituted tricyclics useful in sPLA2 induced diseases
11/21/2001EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001EP1156047A1 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
11/21/2001EP1156046A1 Benzo(5,6)cyclohepta(1,2-B)pyridine derivatives for the inhibition of farnesyl protein transferase
11/21/2001EP1156045A1 Amide derivatives and drug compositions
11/21/2001EP1156044A1 6-substituted heteroquinolinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both
11/21/2001EP1156038A1 2-n-substituted or unsubstituted-2-amino-5-methylpiperidine-3,4-diols and processes for the preparation thereof
11/21/2001EP1155693A1 Intermittent claudication remedies
11/21/2001EP1155678A1 Composition for permanent deformation of hair
11/21/2001EP1155118A2 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of somatic cells
11/21/2001EP1155028A1 Pigment protein from coral tissue
11/21/2001EP1155011A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
11/21/2001EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001EP1155003A1 Novel guanidine derivatives as inhibitors of cell adhesion
11/21/2001EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001EP1154993A1 Thioamide derivatives
11/21/2001EP1154988A1 Mevinolin derivatives
11/21/2001EP1154794A1 Agent containing an additional local anaesthetic for the treatment of symptoms of parkinson's disease
11/21/2001EP1154788A1 Inhibitors of separin, method for identifying them and uses
11/21/2001EP1154786A2 Methods and compositions for altering mucus secretion
11/21/2001EP1154785A2 Inhibitors for use in hemostasis and immune function
11/21/2001EP1154773A2 Use of antagonists of pg-e for the treatment of neuropathic pain
11/21/2001EP1154769A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
11/21/2001EP1154767A1 Substituted stilbene compounds with vascular damaging activity
11/21/2001EP1154764A1 Epoxide hydrolase complexes and methods therewith
11/21/2001EP1154691A1 Targeted transscleral controlled release drug delivery to the retina and choroid
11/21/2001EP1007085B1 Use of growth hormone in compositions for treating insulin resistance in the heart
11/21/2001EP0998292B1 Method for inhibiting bone resorption
11/21/2001EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001EP0873340B1 Heterocyclic substituted cyclopentane compounds
11/21/2001EP0833638B1 USE OF IMIDAZO 1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS
11/21/2001EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001EP0772613B1 Process for the production of aminoazobicycloalkanes from oximes
11/21/2001EP0767676B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions
11/21/2001EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
11/21/2001EP0659179B1 Benzo-fused lactams promote release of growth hormone
11/21/2001EP0650480B1 1-arylsulphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
11/21/2001EP0536186B1 Bone and cartilage inductive proteins
11/21/2001CN1323396A Endogenous constitutively activated G protein-coupled orphan receptors
11/21/2001CN1323348A Delivery system for porcine somatotropin
11/21/2001CN1323314A Inhibitors of caspases
11/21/2001CN1323309A Phenyl yanthine derivatives
11/21/2001CN1323307A 1H-imidazopyridine derivatives
11/21/2001CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001CN1323295A AZA-bicycles which modulate the inhibition of cell adhesion
11/21/2001CN1323294A Cyclic ester or amide derivatives
11/21/2001CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001CN1323222A LT and CT in parenteral immunization methods against helicobacter infection
11/21/2001CN1323218A The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives
11/21/2001CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001CN1323213A Blood-brain barrier therapeutics
11/21/2001CN1323212A A method of modulating ion channel functional activity
11/21/2001CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001CN1323205A Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders
11/21/2001CN1323203A FC receptor modulators and uses thereof
11/21/2001CN1323200A New oral formulation for 5-HT4 agonists or antagonists
11/21/2001CN1323199A Liposome-entrapped topoisomerase inhibitors
11/21/2001CN1323186A Two chamber cartridge for atomizers
11/21/2001CN1323181A Method and device for preparing a dental implant by immersion in a mesenchymal cell culture
11/21/2001CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001CN1322725A Indole derivant
11/21/2001CN1322570A Chinese medicine preparation for treating spinal damage and its preparing method
11/21/2001CN1322569A Method of preparing Qingjiangpian tablets for clearing heat and detoxicating
11/21/2001CN1322547A Hernia treating Chinese medicine
11/21/2001CN1322541A Medicine powder, pill and capsule for keeping the adverse energy downwards and their preparation
11/21/2001CN1322526A Compound for treating female sexual dysfunction
11/21/2001CN1322524A Use of pentanoate derivant
11/21/2001CN1075070C Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
1 ... 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 ... 1564